|
Passing
the Torch: New Editorial Team Offers Broadest Spectrum
of Expert Medical Opinion in Pulmonary Hypertension
This issue of Advances in Pulmonary
Hypertension renews our commitment to the pulmonary
hypertension community to provide valuable, timely,
peer-reviewed scientific information relevant to clinical
practice. Beginning with its first issue more than
3 years ago, the journal has embodied a team effort.
Reflecting the fact that pulmonary hypertension is
a complex disease, our editorial focus has been derived
from experts whose areas of concentration reflect
the diverse nature of this disorder and its complications.
As I assume the role of Editor-in-Chief,
I pursue the same strategy because it has served us
well. We will continue to build on a team effort of
national and international experts whose goal is to
find a cure for pulmonary hypertension. While the
cure remains elusive, we are finding significant ways
to improve the quality of life of patients with the
disease; the journal serves as a chronicle of that
story as it focuses on important developments in translational
research and relates them to clinical considerations
and decisions.
We are challenged by and appreciative
of the leadership provided during the first 3 years
of publication. We gratefully acknowledge the hard
work and guidance provided by Victor F. Tapson, MD,
Editor-in-Chief during this time. His contribution
to the launch of the journal has left us with a solid
foundation on which to build. His high editorial standards
give us a legacy to live up to and the enthusiastic
response to the journal from 30,000 readers makes
us proud of Vics contribution. We are also grateful
for the guidance provided by the Editorial Advisory
Board of Richard N. Channick, MD, Sean Gaine, MD,
PhD, Ronald J. Oudiz, MD, and Ivan M. Robbins, MD.
The help from these leading academicians in identifying
appropriate topics, participating in roundtable discussions
and ensuring the overall quality of content inspires
us to continue their excellent work.
With this issue, you will see more
evidence of our team approach to pulmonary hypertension.
Drs Channick and Oudiz will remain as Associate Editors,
and we have added Ramona Doyle, MD, Karen Fagan, MD,
and Oliver Sitbon, MD. Our Editorial Advisory Board
has been expanded because more physicians have expressed
a special interest in the journal and we look forward
to working with them throughout the year as they participate
in the editorial process. These physicians include:
Gregory Ahearn, MD, Jacques Benisty, MD, Raymond Benza,
MD, Erika Berman-Rosenzweig, MD, Todd Bull, MD, Murali
Chakinala, MD, Jeffrey Edelman, MD, Jim Maloney, MD,
Robert Schiltz, DO, and Roxana Sulica, MD. (read
more...)
Vallerie V. McLaughlin, MD
Editor-in-Chief
|